PITX2 and esophageal squamous cell carcinoma: In addition to the tumor promotive role, PITX2 also functioned as a poor prognostic biomarker for breast cancer [11], colorectal carcinoma [12], head and neck squamous cell carcinoma [13], and esophageal squamous cell carcinoma [14].